Name | {5-[(Z)-{2-[(4-Fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene}amino]-2-oxo-1,3-benzoxazol-3(2H)-yl}methyl dihydrogen phosphate |
---|---|
Synonyms |
2(3H)-Benzoxazolone, 5-[[(4Z)-2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene]amino]-3-[(phosphonooxy)methyl]-
{5-[(Z)-{2-[(4-Fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4(3H)-pyrimidinylidene}amino]-2-oxo-1,3-benzoxazol-3(2H)-yl}methyl dihydrogen phosphate |
Description | Fosifidancitinib is a potent and selective inhibitor of JAK kinases 1/3. Fociatinib is used in studies of allergies, asthma and autoimmune diseases[1]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 723.1±70.0 °C at 760 mmHg |
Molecular Formula | C21H21FN5O7P |
Molecular Weight | 505.39 |
Flash Point | 391.1±35.7 °C |
Exact Mass | 505.116272 |
LogP | 2.15 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |
Index of Refraction | 1.680 |